|
|
Volumn 11, Issue 4, 2011, Pages 249-252
|
|
Fimasartan
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMLODIPINE;
ATORVASTATIN;
DIGOXIN;
FIMASARTAN;
HYDROCHLOROTHIAZIDE;
KETOCONAZOLE;
LOSARTAN;
RIFAMPICIN;
VALSARTAN;
WARFARIN;
ANTIHYPERTENSIVE ACTIVITY;
COMBINATION CHEMOTHERAPY;
DIZZINESS;
DRUG ABSORPTION;
DRUG DOSE INCREASE;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
ESSENTIAL HYPERTENSION;
HUMAN;
HYPERTENSION;
HYPOTENSION;
MONOTHERAPY;
NONHUMAN;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
REVIEW;
SINGLE DRUG DOSE;
ANGIOTENSIN RECEPTOR ANTAGONISTS;
ANTIHYPERTENSIVE AGENTS;
BIPHENYL COMPOUNDS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
HYPERTENSION;
PYRIMIDINES;
TETRAZOLES;
|
|
EID: 79960230902
PISSN: 11753277
EISSN: 1179187X
Source Type: Journal
DOI: 10.2165/11533640-000000000-00000 Document Type: Review |
|
Times cited : (10)
|
|
References (5)
|
